AnalytiChem Expands Global Footprint with Acquisition of Cherwell Laboratories

Cherwell Laboratories, a leading provider of solutions in aseptic microbiology environments, has been purchased by AnalytiChem, a worldwide corporation with branches located in Australia, Europe, and North America.  

Andy Whittard, Cherwell’s CEO, continued to build the company’s emphasis on environmental and procedure surveillance of pharmaceuticals, eventually branching out into the fields of industry and healthcare.    

Whittard stated, “Within the AnalytiChem group, Cherwell will be able to leverage collaboration opportunities, especially with our new sister company BioTrading, alongside our focused offering of environmental and process monitoring products to the pharmaceutical manufacturing sector.”  

The chief officer at AnalytiChem Group, Raoul Biskupek, stated that the acquisition of Cherwell allowed the company to provide a platform that was even more proficient.  

Biskupek added, “This complementary offering opens exciting growth opportunities for our subsidiaries in the adjacent countries and our strong distribution partners network.”  

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.